Esteve Pharmaceuticals GmbH


Purpose of the company: The research, development, manufacture, and distribution of pharmaceutical preparations in the human and veterinary sectors, as well as food products, dietary supplements, body care products, cosmetics, and medical devices, as well as the acquisition of other companies with similar business activities, in particular Riemser Arzneimittel AG.

Adress: Hohenzollerndamm 150 - 151 14199 Berlin Deutschland

Local court: 14057 Berlin (Charlottenburg)

Register number: HRB234788B


Free
Credit Report


Total assets

The average total assets of company Esteve Pharmaceuticals GmbH over the last 2 years is 84.972.529,67 €.

The company Esteve Pharmaceuticals GmbH as of the reporting date 2022 a bank balance of approx. 1.087.063,99 €. That is -90,22 % less than the average bank balance in the industry of companies with this total assets.


Equity ratio

The equity ratio of Esteve Pharmaceuticals GmbH is 60,26 % in the year 2022. In total, that ist 44.034.848,34 €.


Change in liquidity compared to previous year

The average absolute change in liquidity of the company Esteve Pharmaceuticals GmbH compared to the previous year amounts to -2.936.660,69 €. That means that the liquidity of the company has increased or decreased by this amount per year on average.

The cash flow of the company Esteve Pharmaceuticals GmbH amounts to -2.936.660,69 € in the year 2022.


Publication dates of the annual financial statements

  • 2021: 15.05.2023
  • 2022: 16.07.2024

The publication dates refer to the date on which the company published its annual financial statements in the company register. This information can provide important insights into the management of the company.


Source and reliability of the data

The information presented here comes from publicly accessible sources, in particular the Unternehmensregister, in which companies are obliged to disclose their annual financial statements (Sections 325 et seq. of the German Commercial Code (HGB)).

All key financial figures are based on the companies' published annual financial statements. The information is analysed automatically by Bonscore, without content processing or interpretation.

Please note that despite the utmost care, no guarantee can be given that the information provided is up-to-date, complete or correct.